Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
bioZhena Corporation Private Placement Offering and/or Strategic Alliance Proposal 8/3/2017 bioZhena Corporation 1 Target Customers’ Profile 30% Sub-fertile 70% Birth control 100% Cervical health cancer, STDs Three statistics tell the story Personalized medicine - diagnostic tools $232 Billion personalized medicine market to grow 11% annually said PricewaterhouseCoopers bioZhena Corporation 70% of women “would switch” 70% of women who would buy the Ovulona Smart Sensor, would switch from their current birth control to our fertility status monitor [from a survey of 5,000 US women] bioZhena Corporation Cervical Cancer/STD Screen Innocuous affordable triage for colposcopy-biopsy Billions women globally. Tens of millions reproductive-age women in the U.S. alone. This screen is for everyone. Affordable. Private. Solid. As the sensor monitors cervical tissues, other STDs will be detected. Sexually Transmitted Diseases bioZhena Corporation Friendly Technology From Home to Healthcare Providers From patients’ Ovulona™ units to physician’s Ovulograph™ – when needed bioZhena Corporation Applications, apps Helping to Conceive Pregnancy Managing Menstrual Cycle Natural Birth Control Managing Menopause Cervical Cancer, STD Screening bioZhena Corporation Total Available Market Cervical cancer screening is an estimated annual $5B US Pap smear test market. Worldwide extrapolation: >$100B annually. Ovulona™ will save an est. 50% - 90%. Segments of bioZhena’s target market: Trying to Conceive Pregnancy Market Managing Menstrual Cycle Market U.S. Birth Control Market World Managing Menopause Market Cervical Health Screening Market 8/3/2017 bioZhena Corporation ~$ 25B >$500B 7 bioZhena Corporation’s Offering Personalized Health Management bioZhena Corporation Contact [email protected]